Aventis Sues Sandoz Over Generic Taxotere
Aventis Pharma SA and Sanofi-Aventis US LLC have filed a patent infringement suit seeking to block Sandoz Inc.'s efforts to market a generic version of cancer treatment Taxotere....To view the full article, register now.
Already a subscriber? Click here to view full article